Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Morning Report: Multiple Sclerosis

Monday 04/12/10
07:00 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Morning Report
John Corboy, MD, FAAN
Participants should be familiar with the differential diagnosis, evaluation, and treatment of a complex multiple sclerosis patient.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Interactive, Audience Participation
Event Timeline
06:45 AM - 08:30 AM Break
07:00 AM - 08:30 AM Morning Report: Multiple Sclerosis
John Corboy, MD, FAAN
Faculty Disclosures
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.